Ipramol Steri-Neb

Ipratropium bromide and salbutamol, the active ingredients in Ipramol Steri‑Neb, are a combination bronchodilator presented as an inhalation formulation for respiratory use. The formulation combines an anticholinergic agent with a short‑acting β2‑agonist to provide rapid relief of airway constriction in patients with chronic obstructive pulmonary disease (COPD) and asthma.\n\nGNH India supplies Ipramol Steri‑Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipramol Steri‑Neb, a combination bronchodilator, is used to manage airway constriction in obstructive lung diseases.\n\nCOPD bronchospasm: provides rapid bronchodilation and symptom relief.\nAsthma bronchospasm: alleviates acute episodes and improves airflow.\nExercise‑induced bronchoconstriction: may be used as needed to prevent symptoms.\nChronic bronchitis: reduces episodes of wheezing and dyspnea.

Common Side Effects:\n- Dry mouth\n- Throat irritation\n- Cough\n- Tremor\n\nSerious or Rare Side Effects:\n- Paradoxical bronchospasm\n- Angioedema\n- Severe allergic reaction

Before initiating therapy, consider the following precautions.\n\nAssess cardiac history: monitor for tachycardia or arrhythmias.\nEvaluate for glaucoma: anticholinergic may increase intraocular pressure.\nUse with caution in patients with diabetes: monitor blood glucose levels.\nAvoid in patients with known hypersensitivity to ipratropium or salbutamol.\nStore at ambient temperature: keep in original container, protect from moisture and light.

Ipramol Steri‑Neb may interact with other medicines.\n\nMajor Interactions (Avoid):\n- Beta‑blockers: may reduce bronchodilator effect.\n- MAO inhibitors: risk of hypertensive crisis.\n- Tricyclic antidepressants: may increase anticholinergic load.\n\nModerate Interactions (Monitor Closely):\n- Diuretics: may enhance hypokalemia.\n- Theophylline: additive stimulant effect.\n- Corticosteroids: may increase risk of oral thrush.